Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Dis-Chem PharmaciesJSE:DCP -3.17%88 ROC (Joel Greenblatt) % is 19.16% as of Feb. 2026, which is 41% below its 10-year median of 32.34. GuruFocus rates JSE:DCP with a GF Score™ of 88/100 and a GF Value™ of R38.28 (Modestly Undervalued). The stock has 3 warning signs investors should review. Among 666 Healthcare Providers & Services companies, Dis-Chem Pharmacies ranks better than 69.37% on this metric.
Joel Greenblatt defined Return on Capital differently in his book The Little Book That Still Beats the Market (Little Books. Big Profits). He defines ROC (Joel Greenblatt) % as EBIT divided by the total of Property, Plant and Equipment and net working capital. Dis-Chem Pharmacies's annualized ROC (Joel Greenblatt) % for the quarter that ended in Feb. 2026 was 19.16%.
The historical rank and industry rank for Dis-Chem Pharmacies's ROC (Joel Greenblatt) % or its related term are showing as below:
JSE:DCP'
s ROC (Joel Greenblatt) % Range Over the Past 10 Years
Min: 24.98 Med: 32.34 Max: 48.47
Current: 24.98
During the past 13 years, Dis-Chem Pharmacies's highest ROC (Joel Greenblatt) % was 48.47%. The lowest was 24.98%. And the median was 32.34%.
JSE:DCP's ROC (Joel Greenblatt) % is ranked better than 69.37% of 666
companies
in the Healthcare Providers & Services industry
Industry Median: 12.485
vs JSE:DCP: 24.98
Dis-Chem Pharmacies's 5-Year average Growth Rate of ROC (Joel Greenblatt) % was -3.70% per year.
The way Joel Greenblatt defines Return on Capital is a more accurate measure of how efficiently the company generates returns onthe capital actually invested in the business. EBIT is used instead of net income because the tax and interest payment may be affected by factors other than the core business operation. Intangible assets are not included in the calculation because they don't need to be replaced.
Dis-Chem Pharmacies ROC (Joel Greenblatt) % Related Terms
Dis-Chem Pharmacies ROC (Joel Greenblatt) % Historical Data
* Premium members only.
The historical data trend for Dis-Chem Pharmacies's ROC (Joel Greenblatt) % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Pharmaceutical Retailers subindustry, Dis-Chem Pharmacies's ROC (Joel Greenblatt) %, along with its competitors' market caps and ROC (Joel Greenblatt) % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Dis-Chem Pharmacies ROC (Joel Greenblatt) % vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, Dis-Chem Pharmacies's ROC (Joel Greenblatt) % distribution charts can be found below:
* The bar in red indicates where Dis-Chem Pharmacies's ROC (Joel Greenblatt) % falls into.
Joel Greenblatt defined Return on Capital differently in his book The Little Book That Still Beats the Market (Little Books. Big Profits) . He defines Return on Capital as follows:
EBIT stands for Earnings Before Interest and Taxes.
Fixed Assets are also known as non-current assets. They include the Property, Plant and Equipment that the firm needs in its operation.
GuruFocus calculates net working capital as: (Accounts Receivable + Total Inventories + Other Current Assets) - (Accounts Payable & Accrued Expense + Deferred Revenue + Other Current Liabilities). We're trying to account for OPERATING assets and liabilities (part of daily business) when calculating working capital. Cash and marketable securities are considered NON-OPERATING assets and are not included in calculation. We will also back out all interest bearing debt, short term debt and the portion of long term debt that is due in the current period from the current liabilities. This debt will be considered when computing cost of capital and it would be inappropriate to count it twice.
Note:
The EBIT data used here is two times the semi-annual (Feb. 2026) EBIT data.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
What does a ROC (Joel Greenblatt) % of 19.16% mean?
Dis-Chem Pharmacies (JSE:DCP) has a ROC (Joel Greenblatt) % of 19.16% as of Feb. 2026. Joel Greenblatt's return on capital is the ratio of EBIT to average fixed assets and net working capital. View historical data on Dis-Chem Pharmacies and its competitors. This is 41% below median its historical median of 32.34. Over the past decade, Dis-Chem Pharmacies' ROC (Joel Greenblatt) % has ranged from 24.98 to 48.47. According to the industry distribution chart, Dis-Chem Pharmacies ranks #204 out of 666 companies in the Healthcare Providers & Services industry, placing it in the top 30.6%.
Is Dis-Chem Pharmacies' ROC (Joel Greenblatt) % too high?
Dis-Chem Pharmacies' current ROC (Joel Greenblatt) % of 19.16% is 41% below median its 10-year median of 32.34. Over the past 10 years, this metric has ranged from a low of 24.98 to a high of 48.47. The Healthcare Providers & Services industry median ROC (Joel Greenblatt) % is 12.49. Dis-Chem Pharmacies' value of 19.16% is 53.5% above this industry median. Based on the distribution chart, Dis-Chem Pharmacies ranks #204 out of 666 companies in the Healthcare Providers & Services industry, which is above the industry midpoint. Overall, Dis-Chem Pharmacies has a GF Score™ of 88/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Dis-Chem Pharmacies' ROC (Joel Greenblatt) % compare to competitors?
According to the Healthcare Providers & Services industry distribution chart, Dis-Chem Pharmacies ranks #204 out of 666 companies for ROC (Joel Greenblatt) %. This puts Dis-Chem Pharmacies in the upper half of its industry. The industry median ROC (Joel Greenblatt) % is 12.49. Dis-Chem Pharmacies' value of 19.16% is 53.5% above this benchmark. Historically, Dis-Chem Pharmacies' own ROC (Joel Greenblatt) % has ranged from 24.98 to 48.47 over the past decade. While the company's 10-year median is 32.34 vs. the industry median of 12.49, Dis-Chem Pharmacies has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good ROC (Joel Greenblatt) % for a Healthcare Providers & Services company?
The median ROC (Joel Greenblatt) % among Healthcare Providers & Services companies is 12.49, based on 666 companies in the industry. Companies in the top quartile (top 25%) have a ROC (Joel Greenblatt) % significantly above this median, while those in the bottom quartile fall well below. However, ROC (Joel Greenblatt) % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Dis-Chem Pharmacies's current ROC (Joel Greenblatt) % of 19.16% is 53.5% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high ROC (Joel Greenblatt) % mean?
A high ROC (Joel Greenblatt) % can signal that a stock is expensive relative to its fundamentals. Joel Greenblatt's return on capital is the ratio of EBIT to average fixed assets and net working capital. View historical data on Dis-Chem Pharmacies and its competitors. For the Healthcare Providers & Services industry, the median ROC (Joel Greenblatt) % is 12.49 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Dis-Chem Pharmacies's current ROC (Joel Greenblatt) % is 19.16%, which is 41% below median its own 10-year median of 32.34. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Dis-Chem Pharmacies stock overvalued right now?
Based on GuruFocus' analysis, Dis-Chem Pharmacies (JSE:DCP) is currently considered Modestly Undervalued. The stock's GF Value™ is R38.28, compared to a current price of R31.14 — trading 18.7% below its estimated fair value. The current ROC (Joel Greenblatt) % is 19.16%, which is 41% below median its 10-year median of 32.34 and 53.5% above the Healthcare Providers & Services industry median of 12.49. Dis-Chem Pharmacies' overall GF Score™ is 88/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is ROC (Joel Greenblatt) % calculated?
ROC (Joel Greenblatt) % is calculated from a company's financial statements. For Dis-Chem Pharmacies (JSE:DCP), the current ROC (Joel Greenblatt) % is 19.16% as of Feb. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Dis-Chem Pharmacies (JSE:DCP) Overvalued in 2026?
Based on GuruFocus' analysis, Dis-Chem Pharmacies stock appears to be undervalued.
The current stock price of R31.14 is trading 18.7% below its estimated GF Value™ of R38.28.
GuruFocus considers Dis-Chem Pharmacies to be Modestly Undervalued.
Key valuation signals for JSE:DCP:
ROC (Joel Greenblatt) %: 19.16% (41% below median its 10-year median of 32.34)
GF Value™: R38.28 vs. price of R31.14 (18.7% below fair value)
Industry Position: 53.5% above the Healthcare Providers & Services median (#204 of 666)
No single metric tells the full story. See the JSE:DCP stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Dis-Chem Pharmacies Ltd is a pharmaceutical company based in South Africa. Its product portfolio includes personal care products, beauty products, healthcare and nutrition products, and dispensary and baby care products. The operating segments of the group are Retail and Wholesale. It derives maximum revenue from the Retail segment, which includes company stores, retailers of pharmaceuticals and a variety of health and beauty products, as well as pharma-logistic services and oncology and retailers of pharmaceutical products. The Wholesale segment consists of the CJ wholesale and company distribution businesses, wholesalers of pharmaceuticals, and a variety of health and beauty products. Geographically, the group carries out its business operations principally in South Africa.
88GF Score
Get the complete analysis for JSE:DCP
ROC (Joel Greenblatt) % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
JSE:DCP has been successfully added to your 
